Science News

Immunotherapy drug opens a new era of precision medicine for cancer

With little fanfare, the Food and Drug Administration did something this week that it's never done before: The agency approved a single prescription drug, pembrolizumab (marketed by Merck as Keytruda) for treatment of solid tumors in any organ so long as the malignancy bears a specific genetic...

Healthy Living: Your Brain

view more

Science and the Trump administration

view more

Science Now

view the blog

Health & Medicine

view more


View more


View more

Nutrition & Obesity

view more

Human Behavior